Quantcast
Last updated on April 16, 2014 at 11:25 EDT

Latest Alex Matter Stories

2013-04-05 00:20:07

National Foundation for Cancer Research (NFCR) honours Professor Alex Matter with esteemed award for groundbreaking cancer pill that gives leukaemia patients a new lease of life.Singapore, Apr 5, 2013 - (ACN Newswire) - Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development...

2013-01-29 12:27:57

BETHESDA, Md., Jan. 29, 2013 /PRNewswire/ -- The National Foundation for Cancer Research (NFCR) announced today that Dr. Alex Matter has been awarded the 8(th) Szent-Gyorgyi Prize for Progress in Cancer Research for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer. This first targeted cancer therapy, imatinib mesylate, or Gleevec, contributed to a major breakthrough in the treatment of Chronic Myelogenous Leukemia (CML), followed by...